Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

INBX

Inhibrx Biosciences Inc.

Jun 21 • 04:00PM ET

15.14

Dollar change +0.65
Percentage change 4.49	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: XBI VTI IWM VXF IWO VTWO IWN IWC FESM SBIO

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	30.48%	Shs Outstand	47.37M	Perf Week	-8.74%
Market Cap	219.23M	Forward P/E	-	EPS next Y	-	Insider Trans	-5.21%	Shs Float	10.06M	Perf Month	-50.76%
Income	-	PEG	-	EPS next Q	-	Inst Own	30.64%	Short Float	12.92%	Perf Quarter	-51.79%
Sales	-	P/S	-	EPS this Y	-	Inst Trans	32.31%	Short Ratio	2.48	Perf Half Y	-43.78%
Book/sh	0.23	P/B	64.44	EPS next Y	-	ROA	-	Short Interest	1.30M	Perf Year	-37.21%
Cash/sh	17.44	P/C	0.87	EPS next 5Y	-	ROE	-	52W Range	12.85 - 35.73	Perf YTD	-55.63%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-57.63%	Beta	2.61
Dividend TTM	-	Quick Ratio	3.82	Sales past 5Y	-17.88%	Gross Margin	-	52W Low	17.86%	ATR (14)	1.27
Dividend Ex-Date	-	Current Ratio	3.82	EPS Y/Y TTM	-	Oper. Margin	-	RSI (14)	27.13	Volatility	8.21% 6.39%
Employees	-	Debt/Eq	18.23	Sales Y/Y TTM	-	Profit Margin	-	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	17.73	EPS Q/Q	-	Payout	-	Rel Volume	1.60	Prev Close	14.49
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	523.16K	Price	15.14
SMA20	-20.24%	SMA50	-42.04%	SMA200	-40.39%	Trades		Volume	836,121	Change	4.49%

Inhibrx Biosciences, Inc. operates as an American clinical-stage biotechnology company for biologic therapeutic candidates. The private company is based in DE.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kayyem Jon Faiz	Director	Jun 05 '24	Buy	17.32	57,549	997,024	1,150,410	Jun 07 06:05 PM
Eckelman Brendan P.	Chief Scientific Officer	May 28 '24	Sale	34.30	300,000	10,290,000	1,735,553	May 30 06:21 PM
VIKING GLOBAL INVESTORS LP	10% Owner	Aug 28 '23	Buy	19.35	511,627	9,899,982	511,627	Aug 30 08:44 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

INBX

Inhibrx Biosciences Inc.

Upgrade your FINVIZ experience